A five-center collaborative study was undertaken to develop quality control and specific interpretive criteria for susceptibility testing of Streptococcus pneumoniae against 12 antimicrobial agents. MICs 15, 24, 26, 29, 37) . The prevalence of such strains has increased sharply in the United States since 1988 (4, 12, 19, 40, 44, 47). Reports of broad-spectrum cephalosporin resistance have made empirical therapeutic choices for serious infections such as meningitis very problematic (2, 10, 39). Because of the marked change in the susceptibility of pneumococci to commonly used antimicrobial agents, there is new interest in reliable methods for susceptibility testing of pneumococcal clinical isolates (9, 10, 20, 24, 38, 43) . This five-center study has developed quality control and proposed interpretive criteria for the broth microdilution and agar disk diffusion tests for several conventional and recently developed antimicrobial agents against S. pneumoniae. pneumoniae were tested in each of the five laboratories. They were either fresh clinical isolates, isolates referred to the laboratories for confirmation of antimicrobial resistance, or isolates selected from among the laboratories' stock culture collection to assure adequate numbers of resistant strains. These included 56 penicillin-resistant, 85 penicillin-intermediate, and at least 11 extended-spectrum cephalosporin-resistant strains.
Streptococcus pneumoniae clinical isolates resistant to penicillin or multiply resistant to several antimicrobial agent classes have been reported with increasing frequency in recent years throughout the world (5, 15, 24, 26, 29, 37) . The prevalence of such strains has increased sharply in the United States since 1988 (4, 12, 19, 40, 44, 47) . Reports of broad-spectrum cephalosporin resistance have made empirical therapeutic choices for serious infections such as meningitis very problematic (2, 10, 39) . Because of the marked change in the susceptibility of pneumococci to commonly used antimicrobial agents, there is new interest in reliable methods for susceptibility testing of pneumococcal clinical isolates (9, 10, 20, 24, 38, 43) . This five-center study has developed quality control and proposed interpretive criteria for the broth microdilution and agar disk diffusion tests for several conventional and recently developed antimicrobial agents against S. pneumoniae.
MATERIALS AND METHODS
Participant laboratories. Studies were conducted in five collaborating laboratories. They included Centers for Disease Control and Prevention (Atlanta, Ga.), Massachusetts General Hospital (Boston, Mass.), University of California, Los Angeles, Medical Center (Los Angeles, Calif.), Washington University and Barnes Hospital (St. Louis, Mo.), and University of Texas Health Science Center (San Antonio, Tex.).
S. PNEUMONIAE TESTING 2449 laboratory. Inocula were prepared by suspending growth obtained from sheep blood agar plates that had been incubated for 20 to 24 h in 5% CO2. Colonies were suspended in 0.9% saline to obtain a suspension turbidity equivalent to a 0. 5 McFarland standard. The suspension was further diluted within 15 min to provide a final inoculum density of 5 x 105 CFU/ml in the wells of the microdilution trays. Colony counts were performed to ensure appropriate inoculum concentrations. Microdilution trays were incubated at 35°C in ambient air for 20 to Development of quality control ranges and interpretive criteria. Data from all of the laboratories were analyzed to establish acceptable quality control limits for MICs and zone diameters for each drug according to the criteria advocated by the NCCLS (31) . MICs and zone sizes for each drug were compared by scatter plots of the data generated by testing the clinical isolates in each laboratory. Proposed zone sizes were developed by use of the error-rate-bounded method (27) . Fig. 1 for each drug. Interpretive criteria were first established for MICs of each drug (see Discussion); then, zone diameter interpretive criteria were proposed for each agent through use of the error-rate-bounded method (27) to select zone diameter breakpoints which would provide the fewest interpretive errors. Table 3 includes the proposed MIC and zone diameter interpretive criteria and a calculation of the interpretive errors which resulted from applying the proposed breakpoints to the data generated in this study. The correlation between MICs (Table 3 ). The majority of errors occurred with strains whose penicillin MICs reflected borderline susceptibility to penicillin (MIC = 0.06 ,ug/ml) and which produced zone diameters of 13 to 17 mm.
RESULTS

Each
DISCUSSION
The prevalence of S. pneumoniae clinical isolates resistant to primary therapeutic agents such as penicillin, chloramphenicol, trimethoprim-sulfamethoxazole, and tetracycline appears to have changed markedly in the last 2 to 5 years (4, 5, 24, 29, 44). In addition, reports of pneumococci resistant to various extended-and broad-spectrum cephalosporins have occurred for the first time during this period (2, 6, 10, 39). These developments have placed greater emphasis on prompt and accurate recognition of resistant pneumococcal isolates by clinical microbiology laboratories.
The MIC procedure recommended by the NCCLS (34) for testing pneumococci includes the use of MHLHB. Lysed horse blood-supplemented medium has been criticized as being tedious to prepare and not widely available from commercial sources. For those reasons Haemophilus test medium (HTM) was explored as an alternative to MHLHB (18, 20, 32) ; however, MICs tended to be somewhat lower in HTM than MICs in MHLHB, a finding which can affect the interpretation of results with some drugs (18) . Perhaps more importantly, excessive growth failures and significantly lower MICs were seen with some contemporary lots of HTM used for pneumococcal testing in an early phase of the present study (data not shown). Because of these unexplained problems with some lots of HTM, we cannot recommend HTM at this time as an alternative to MHLHB for MIC testing of pneumococci.
The definitions of penicillin resistance in current use (34) are derived from the original breakpoints proposed by Hansman (13) and later endorsed by Jacobs et al. (16, 17) . Thus, the definition of penicillin resistance used in this study was an MIC 2 2 ,ug/ml, and MICs of 0.12 to 1 ,ug/ml were referred to as intermediate rather than "relatively resistant," for consistency with breakpoints proposed for the other agents studied. The oxacillin disk test has been found in prior studies to be reliable for predicting susceptibility to penicillin (24, 41 ). An acknowledged shortcoming of the oxacillin disk test is its inability to distinguish between strains that are penicillin resistant from those that are intermediately resistant to penicillin or those that demonstrate borderline susceptibility to penicillin (especially MICs of 0.06 ,ug/ml) (41, 48) . However, the data from the present study reaffirm the concept that susceptible strains of pneumococci reliably produce zones of 20 mm or greater with the oxacillin disk screening test (Fig. 1) . It is our view that it is important to define precisely the level of penicillin susceptibility of significant pneumococcal isolates (especially those causing meningitis) by determining an MIC. In areas with very low rates of penicillin resistance (e.g., less than 5%) or with isolates from patients who do not have meningitis, it may be considered cost-effective to screen isolates with the oxacillin disk test and to pursue MIC testing with penicillin and alternative agents only on isolates that have oxacillin zone sizes less than 20 mm. Current evidence indicates that high-dose penicillin (12 x 106 to 24 x 106 U/day given intravenously for adults) may be used to treat penicillin-intermediate pneumococcal infections outside the central nervous system (15, 23, 36, 38) . However, clinical experience has shown that penicillin is not an adequate regimen for treatment of penicillin-resistant or -intermediate strains in patients who have meningitis (14, 15, 36, 45, 46) .
Chloramphenicol resistance in pneumococci is most often due to production of the inactivating enzyme chloramphenicol acetyltransferase (19, 25) . Chloramphenicol MICs for such strains are 8 ,ug/ml or greater (19) . On the basis of the results of the present study, such strains can be accurately recognized by disk diffusion testing using the breakpoint indicated in Table 3 . However, recent clinical experience in the use of chloramphenicol to treat meningitis due to penicillin-resistant pneumococcal strains has not been favorable (8 amphenicol alone may not represent optimal therapy of pneumococcal meningitis due to penicillin-resistant strains, even when a chloramphenicol-susceptible strain is implicated.
Until recently, extended-spectrum cephalosporins have been used successfully for therapy of serious pneumococcal infections such as meningitis, including those due to penicillinresistant or -intermediate strains (6, 22, 36, 46) . Most pneumococcal strains have had cefotaxime or ceftriaxone MICs of s0.03 pLg/ml (15, 23) . However, pneumococcal strains with cefotaxime or ceftriaxone MICs of 2 to 32 ,ug/ml have been recognized recently in patients who have meningitis and who have failed treatment with either of those cephalosporins (2, 10, 39). Certain of these cephalosporin-resistant strains have shown intermediate susceptibility to penicillin (MICs of 0.25 to 0.5 ,ug/ml), while others have been penicillin resistant (2, 10) . Cephalosporin resistance in these strains appears to be due to unique remodeling of the penicillin-binding proteins, which differs somewhat from the penicillin-binding-protein alterations that result in penicillin (but not cephalosporin) resistance (7, 30) .
Clinical response to cefotaxime or ceftriaxone therapy has varied, with MICs of 0.5 to 1 ,g/ml. In one study, seven of nine adult patients with meningitis responded favorably to cefotaxime therapy (200 to 350 mg/day) (45). It is not clear from that study if the patients with strains in the higher cephalosporin MIC range (0.5 to 1 pug/ml) responded less favorably than those for whose strains the MICs were lower (e.g., -0.03 jig/ml). However, a child with meningitis caused by a strain for which the MIC was 1 j,g/ml failed therapy with low-dose (150 mg/kg of body weight) cefotaxime (1) . A single patient described in a letter to the editor was said to fail therapy with cefotaxime for a strain with a cefotaxime MIC of 0.5 ,ug/ml (3). The methodologies used to determine the cephalosporin MICs in some of the aforementioned studies have not been described in detail, making method-or medium-dependent differences impossible to distinguish. The aforementioned clinical responses combined with knowledge that cerebrospinal fluid levels of either cefotaxime or ceftriaxone are usually in the range of 4 to 4.5 ,ug/ml (10, 39) have led us to propose that pneumococcal isolates with cefotaxime or ceftriaxone MICs of 2 jig/ml or greater be regarded as resistant, at least with respect to patients with meningitis. On the basis of a review of the extant literature and unpublished clinical studies reviewed by the NCCLS Antimicrobial Susceptibility Testing Subcommittee, it is likely that strains for which MICs are <0.5 ,ug/ml will be responsive to therapy with high doses of either of these cephalosporins and, thus, should be categorized as susceptible. (34) on the basis of the reasoning that pneumococci and Haemophilus species often produce similar localized, non-life-threatening respiratory infections that might be expected to respond in a similar manner to oral beta-lactam therapy. However, it is our present opinion that the MIC interpretive criteria for those oral cephalosporins are too high for use with pneumococci. Evidence that penicillin-intermediate or -resistant pneumococci are clinically responsive to therapy with oral cephalosporins has not been provided. Additional data relevant to the activity of several oral betalactams against pneumococci are under evaluation and will be the subject of a future article and later recommendations by the NCCLS.
Imipenem has been suggested as a possible therapeutic alternative for the cephalosporin-resistant pneumococcal strains (45) and has been used successfully to treat one patient with a cefotaxime-resistant isolate (1) . However, the cerebrospinal fluid penetration of imipenem may not be optimal for treatment of meningitis without causing the unwanted side effect of seizures (28) . On the basis of the very limited data available, we tentatively propose that pneumococci with MICs of 0.12 ,ug/ml be categorized as susceptible and that strains with MICs of 1 ,ug/ml or greater be regarded as resistant (Table 3) . Unfortunately, the disk diffusion test was found to correlate poorly with imipenem MICs (Fig. 1E) and cannot be recommended for testing of this agent.
The MIC interpretive criteria used for nonfastidious organisms (34) seem to characterize accurately levels of susceptibilities of pneumococci to erythromycin and ofloxacin ( Fig. 1H and L, respectively, and Table 3 ). However, only criteria which define susceptibility to vancomycin (MIC c 1 ,ug/ml; zone diameter 2 17 mm) can be proposed since vancomycinresistant pneumococcal strains do not exist at this time ( Fig. 1K and Table 3 ).
We propose adoption of the MIC interpretive criteria in current use for Haemophilus species (34) 
